4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 475.00
0.00 (0.00%)
Sep 4, 2026, 1:50 PM GMT
4basebio Market Cap
4basebio has a market cap or net worth of 73.81 million as of September 4, 2026. Its market cap has decreased by -46.12% in one year.
Market Cap
73.81M
Enterprise Value
72.49M
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
475.00
ChartMarket Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 73.81M, an increase of 77.54%. That is a compound annual growth rate of 10.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 73.81M | -22.46% |
| Dec 31, 2025 | 95.19M | -38.57% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.37M |
| Bioventix | 90.39M |
| Faron Pharmaceuticals Oy | 72.43M |
| Poolbeg Pharma | 62.91M |
| Ondine Biomedical | 59.75M |
| Sareum Holdings | 48.50M |
| hVIVO | 47.40M |
| Hemogenyx Pharmaceuticals | 35.63M |